Source: PR NEWSWIRE

Press Release: Oxford BioTherapeutics : Oxford BioTherapeutics to Present at 35th Cowen and Company Annual Health Care Conference in Boston

OXFORD, England and SAN JOSE, California, February 23, 2015 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer, announces that it will present at the 35th...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Christian Rohlff's photo - Founder & CEO of OBT

Founder & CEO

Christian Rohlff

CEO Approval Rating

86/100

OBT is a biotechnology company that focuses on the discovery and development of therapeutics for the treatment of cancer. Read more